Therapeutic Areas
8,607+
FDA Drugs
33,295
Active Trials
19
Therapeutic Areas
🧬
Oncology
+102 since 2024 710 drugs
22,092 trials
40 indications
Solid Tumor (Advanced), Breast Cancer, Non-Hodgkin Lymphoma ...
Leaders: Pfizer, Novartis, HIKMA
🧠
CNS
+40 since 2024 867 drugs
2,186 trials
18 indications
Major Depression, Alzheimer's Disease, Schizophrenia ...
Leaders: AbbVie, Novartis, HIKMA
❤️
Cardiovascular
+35 since 2024 1,024 drugs
1,476 trials
9 indications
Hypertension, Heart Failure, Stroke ...
Leaders: B BRAUN, Pfizer, Novartis
⚗️
Metabolic
+24 since 2024 348 drugs
1,438 trials
7 indications
Type 2 Diabetes, Obesity, Diabetes (General) ...
Leaders: Eli Lilly, Novartis, NOVO NORDISK INC
🛡️
Immunology
+30 since 2024 408 drugs
1,396 trials
15 indications
Rheumatoid Arthritis, Psoriasis, Atopic Dermatitis ...
Leaders: Pfizer, Novartis, AbbVie
🦠
Infectious Disease
+33 since 2024 1,168 drugs
1,186 trials
13 indications
HIV, COVID-19, Influenza ...
Leaders: Pfizer, GSK, APOTHECON
💊
Pain
+9 since 2024 512 drugs
711 trials
4 indications
Acute Pain, Postoperative Pain, Neuropathic Pain ...
Leaders: HIKMA, HALEON US HOLDINGS, Pfizer
🫁
Respiratory
+13 since 2024 437 drugs
636 trials
7 indications
Asthma, COPD, Pneumonia ...
Leaders: Pfizer, Novartis, GSK
🧩
Rare Disease
+22 since 2024 131 drugs
436 trials
9 indications
Sickle Cell Disease, Immune Thrombocytopenia, Hemophilia ...
Leaders: FERRING PHARMS INC, GENZYME CORP, Sanofi
🦴
Musculoskeletal
+3 since 2024 65 drugs
314 trials
4 indications
Osteoarthritis, Osteoporosis, Gout ...
Leaders: Novartis, APIL, WATSON LABS
👁️
Ophthalmology
+13 since 2024 311 drugs
269 trials
3 indications
Age-Related Macular Degeneration, Glaucoma, Dry Eye
Leaders: AbbVie, Novartis, BAUSCH AND LOMB INC
🫘
Renal
+5 since 2024 120 drugs
235 trials
2 indications
Chronic Kidney Disease, Acute Kidney Injury
Leaders: VANTIVE US HLTHCARE, FRESENIUS MEDCL, B BRAUN
🫃
Gastrointestinal
+5 since 2024 265 drugs
217 trials
5 indications
Nausea/Vomiting, Peptic Ulcer, Constipation ...
Leaders: Pfizer, Novartis, GSK
♀️
Women's Health
+7 since 2024 501 drugs
182 trials
5 indications
Infertility, PCOS, Menopause ...
Leaders: BARR, AUROBINDO PHARMA, XIROMED
🧴
Dermatology
+7 since 2024 291 drugs
175 trials
5 indications
Acne, Alopecia, Rosacea ...
Leaders: BAUSCH, Pfizer, SUN PHARMA CANADA
🫀
Hepatology
+4 since 2024 46 drugs
115 trials
2 indications
Cirrhosis, Liver Failure
Leaders: AKARX INC, IPSEN, MIRUM
🚻
Urology
+5 since 2024 81 drugs
109 trials
3 indications
Overactive Bladder, Erectile Dysfunction, Benign Prostatic Hyperplasia
Leaders: AbbVie, Pfizer, VIATRIS
😴
Sleep
40 drugs
77 trials
2 indications
Insomnia, Narcolepsy
Leaders: Pfizer, VANDA PHARMS INC, DR REDDYS LABS SA
⚖️
Endocrine
+5 since 2024 154 drugs
45 trials
5 indications
Growth Hormone Deficiency, Acromegaly, Hypothyroidism ...
Leaders: AbbVie, Novartis, ENDO OPERATIONS
Drug counts based on FDA-approved products with known therapeutic area classification.
Trial counts from ClinicalTrials.gov active studies.